Plante Moran Financial Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $882K | Sell |
959
-600
| -38% | -$608K | 0.06% | 52 |
|
|
2025
Q4 | $1.68M | Buy |
1,559
+21
| +1% | +$20.1K | 0.11% | 26 |
|
|
2025
Q3 | $1.17M | Sell |
1,538
-218
| -12% | -$162K | 0.07% | 41 |
|
|
2025
Q2 | $1.37M | Buy |
1,756
+380
| +28% | +$295K | 0.1% | 36 |
|
|
2025
Q1 | $1.14M | Buy |
1,376
+78
| +6% | +$64.9K | 0.1% | 36 |
|
|
2024
Q4 | $1M | Sell |
1,298
-348
| -21% | -$288K | 0.08% | 45 |
|
|
2024
Q3 | $1.46M | Buy |
1,646
+1
| +0.1% | +$899 | 0.12% | 34 |
|
|
2024
Q2 | $1.49M | Buy |
1,645
+105
| +7% | +$84K | 0.15% | 37 |
|
|
2024
Q1 | $1.2M | Sell |
1,540
-200
| -11% | -$142K | 0.13% | 40 |
|
|
2023
Q4 | $1.01M | Buy |
1,740
+222
| +15% | +$130K | 0.11% | 47 |
|
|
2023
Q3 | $815K | Buy |
1,518
+168
| +12% | +$86.6K | 0.1% | 47 |
|
|
2023
Q2 | $633K | Sell |
1,350
-8
| -0.6% | -$3.35K | 0.07% | 66 |
|
|
2023
Q1 | $466K | Sell |
1,358
-34
| -2% | -$11.5K | 0.06% | 86 |
|
|
2022
Q4 | $509K | Sell |
1,392
-52
| -4% | -$18.4K | 0.07% | 82 |
|
|
2022
Q3 | $467K | Sell |
1,444
-17
| -1% | -$5.39K | 0.08% | 82 |
|
|
2022
Q2 | $474K | Buy |
1,461
+94
| +7% | +$28.2K | 0.08% | 82 |
|
|
2022
Q1 | $391K | Buy |
1,367
+26
| +2% | +$6.69K | 0.07% | 104 |
|
|
2021
Q4 | $370K | Sell |
1,341
-111
| -8% | -$28.1K | 0.06% | 117 |
|
|
2021
Q3 | $335K | Buy |
1,452
+199
| +16% | +$49.1K | 0.07% | 132 |
|
|
2021
Q2 | $288K | Sell |
1,253
-111
| -8% | -$22.3K | 0.07% | 135 |
|
|
2021
Q1 | $255K | Sell |
1,364
-626
| -31% | -$122K | 0.07% | 143 |
|
|
2020
Q4 | $336K | Buy |
1,990
+735
| +59% | +$110K | 0.1% | 118 |
|
|
2020
Q3 | $186K | Hold |
1,255
| – | – | 0.07% | 163 |
|
|
2020
Q2 | $206K | Sell |
1,255
-363
| -22% | -$55.7K | 0.08% | 122 |
|
|
2020
Q1 | $224K | Sell |
1,618
-12
| -0.7% | -$1.65K | 0.1% | 105 |
|
|
2019
Q4 | $214K | Sell |
1,630
-264
| -14% | -$30.6K | 0.07% | 146 |
|
|
2019
Q3 | $212K | Sell |
1,894
-118
| -6% | -$13.1K | 0.06% | 153 |
|
|
2019
Q2 | $223K | Buy |
2,012
+139
| +7% | +$16.4K | 0.07% | 132 |
|
|
2019
Q1 | $243K | Hold |
1,873
| – | – | 0.08% | 131 |
|
|
2018
Q4 | $217K | Sell |
1,873
-15
| -0.8% | -$1.68K | 0.08% | 132 |
|
|
2018
Q3 | $203K | Sell |
1,888
-173
| -8% | -$17.3K | 0.07% | 147 |
|
|
2018
Q2 | $176K | Sell |
2,061
-70
| -3% | -$5.75K | 0.09% | 176 |
|
|
2018
Q1 | $165K | Sell |
2,131
-20
| -0.9% | -$1.61K | 0.09% | 171 |
|
|
2017
Q4 | $182K | Buy |
2,151
+19
| +0.9% | +$1.62K | 0.1% | 151 |
|
|
2017
Q3 | $182K | Sell |
2,132
-29
| -1% | -$2.38K | 0.11% | 141 |
|
|
2017
Q2 | $178K | Buy |
2,161
+88
| +4% | +$7.18K | 0.11% | 133 |
|
|
2017
Q1 | $174K | Sell |
2,073
-27
| -1% | -$2.16K | 0.1% | 140 |
|
|
2016
Q4 | $154K | Buy |
2,100
+15
| +0.7% | +$1.12K | 0.1% | 155 |
|
|
2016
Q3 | $167K | Sell |
2,085
-603
| -22% | -$48.3K | 0.11% | 138 |
|
|
2016
Q2 | $212K | Sell |
2,688
-102
| -4% | -$7.68K | 0.15% | 115 |
|
|
2016
Q1 | $201K | Sell |
2,790
-422
| -13% | -$31.9K | 0.15% | 108 |
|
|
2015
Q4 | $271K | Sell |
3,212
-139
| -4% | -$11.5K | 0.2% | 84 |
|
|
2015
Q3 | $280K | Buy |
3,351
+509
| +18% | +$43K | 0.22% | 83 |
|
|
2015
Q2 | $237K | Sell |
2,842
-149
| -5% | -$11.4K | 0.17% | 101 |
|
|
2015
Q1 | $217K | Sell |
2,991
-32
| -1% | -$2.28K | 0.15% | 106 |
|
|
2014
Q4 | $209K | Sell |
3,023
-350
| -10% | -$23.6K | 0.15% | 100 |
|
|
2014
Q3 | $219K | Buy |
3,373
+320
| +10% | +$20.3K | 0.19% | 89 |
|
|
2014
Q2 | $190K | Buy |
3,053
+1,165
| +62% | +$69.5K | 0.17% | 92 |
|
|
2014
Q1 | $111K | Sell |
1,888
-3,461
| -65% | -$193K | 0.12% | 108 |
|
|
2013
Q4 | $273K | Buy |
5,349
+2,621
| +96% | +$131K | 0.15% | 74 |
|
|
2013
Q3 | $137K | Buy |
2,728
+721
| +36% | +$37.7K | 0.08% | 89 |
|
|
2013
Q2 | $99K | Buy |
+2,007
| New | +$109K | 0.07% | 104 |
|
Other funds holding LLY
VCM
VPM
Plante Moran Financial Advisors's LLY Position: Q1 2026 in Review
Plante Moran Financial Advisors reduced its Eli Lilly (LLY) stake by 38% in Q1 2026, selling an estimated $608K and leaving 959 shares worth $882K. The position accounts for 0.06% of the portfolio, ranked #52.
Plante Moran Financial Advisors first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.68M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Plante Moran Financial Advisors held 959 shares of Eli Lilly worth $882K as of Q1 2026.
- Plante Moran Financial Advisors sold 600 Eli Lilly shares in Q1 2026, an estimated $608K.
- Eli Lilly made up 0.06% of Plante Moran Financial Advisors's portfolio in Q1 2026, its #52 holding.
- Plante Moran Financial Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- Plante Moran Financial Advisors's Eli Lilly position peaked at $1.68M in Q4 2025.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Plante Moran Financial Advisors's 13F filing for Q1 2026, filed 5 May 2026.